Stromal cell-derived factor 1

From WikiMD's WELLNESSPEDIA

Stromal cell-derived factor 1 (SDF-1), also known as C-X-C motif chemokine 12 (CXCL12), is a chemokine protein that in humans is encoded by the CXCL12 gene. It plays a crucial role in hematopoiesis (the formation of blood cellular components) and angiogenesis (the formation of new blood vessels from pre-existing vessels).

Function[edit]

SDF-1 is a member of the CXC chemokine family, a group of small cytokines or signaling proteins secreted by cells. Its primary function is to attract leukocytes towards sites of inflammation or injury. It does this by binding to the chemokine receptor CXCR4, a G protein-coupled receptor found on the surface of certain cells.

In addition to its role in immune response, SDF-1 is also involved in the homing of hematopoietic stem cells to the bone marrow. It is a potent chemoattractant for hematopoietic stem cells, and its interaction with CXCR4 is necessary for the migration of these cells into the bone marrow during embryogenesis.

Clinical Significance[edit]

Given its role in hematopoiesis and angiogenesis, SDF-1 has been implicated in a number of clinical conditions. It is thought to play a role in the pathogenesis of certain cancers, including breast cancer and leukemia, where it may promote tumor growth and metastasis. It has also been associated with cardiovascular diseases such as myocardial infarction and stroke, where it may contribute to the repair and regeneration of damaged tissues.

In addition, SDF-1 and its receptor CXCR4 have been identified as key players in the entry of HIV into cells. This has led to the development of drugs that target this interaction as a potential treatment for HIV infection.

See Also[edit]

References[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.